ArticleFrontiers in public health2026
Putting equity first: reorienting artificial intelligence for population-level postpartum depression prevention.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postpartum depression (PPD) affects 10-20% of new mothers globally, yet detection and treatment rates remain low, particularly in underserved populations. Artificial intelligence (AI)-here spanning supervised machine-learning prediction, natural-language and acoustic analysis, and generative conversational agents-is increasingly promoted as a solution, from risk prediction to chatbot-delivered therapy. Drawing on selected evidence from clinical informatics, digital mental health, public-health ethics, and implementation science, we argue that although AI may genuinely expand reach, its current trajectory, driven by technical feasibility rather than public-health value, could widen rather than narrow maternal mental-health inequities. This risk plays out across four domains: (1) algorithmic accuracy that does not translate into population outcomes; (2) training data that structurally exclude marginalized groups; (3) algorithmic care that may erode relational support; and (4) a regulatory vacuum that permits deployment without accountability. Distinguishing published evidence from our own recommendations, we conclude that AI for PPD prevention should be governed as a public good through equity-centered design, real-world evidence standards (including calibration and subgroup performance beyond AUC), tiered device oversight, layered data consent, and clearly specified safety pathways. We call for a global dialogue among policymakers, developers, health systems, researchers, and women with lived experience to operationalize these principles before large-scale deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.